Patient's Knowledge on Their Anticoagulating and Anti Platelet Treatment St Joseph's Hospital)

Not Applicable

Completed

• Conditions: Coagulation Disorder

• Registration Number: NCT03304977
• Lead Sponsor: Fondation Hôpital Saint-Joseph

Brief Summary

Oral antigoagulant are used more than 60 years in thrombotic diseases. Even they are indispensable, the haemorragic risk is high.That's why it's the main reason of hospitalization for iatrogeny.The complication's reasons are mainly linked to errors of drug intake, drugs interaction and the lack of understanding the treatment.Moreover, the antiplatelet agglutening treatment is frequently added to anticoagulant treatment.This increases the haemorragic risk.Different means were used to minimize the risk , like INR follow up.

The purpose of the study is to evaluate smartphone use to follow the patients'treatment.

Detailed Description

Two questionnaire via smartphone with 15 days gap.

Study Timeline

• Study Start: 2016-06-06
• Primary Completion: 2016-07-31
• Study Completion: 2016-10-30
• Status Verified: 2017-09
• Study First Submitted: 2017-09-29
• Study First Submitted QC: 2017-10-03
• Last Update Submitted: 2017-10-03
• Study First Posted: 2017-10-09
• Last Update Posted: 2017-10-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• patient under ant-thrombotic treatment
• hospitalized in vascular medecine service

Exclusion Criteria

• refusing the participation

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
smartphone use level	15 days	evaluation of the interest of patient to use their smartphone in the purpose to follow their anticoagulant treatment

Trial Locations

Locations (1)

Groupe Hospitalier Paris Saint Joseph; 🇫🇷 Paris, Ile-de-France, France